.After looking at period 1 data, Nuvation Bio has decided to halt work on its own single lead BD2-se...
.Zevra Therapies' unusual illness drug appears to become on the path to authorization this autumn af...
.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene therapy failure has gone a $230 thousand gap...
.After more than twenty years of work on neurodegenerative diseases, Swiss biotech hvac Immune claim...
.GSK has junked a period 2 human papillomavirus (HPV) vaccine from its own pipe after deciding the r...
.OS Therapies will definitely specify on the NYSE American stock substitution this morning using a $...
.ALX Oncology's period 2 gastric cancer cells feedback rate has actually damaged. After observing it...
.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of desires, causin...
.While Biogen's pharma peers are actually searching for late-stage properties with little bit of thr...
.Instil Biography has been a biotech searching for a pipe after it junked its lead properties over t...